"In Guardian Angel Health Services Inc we help patients in Tampa Bay, Florida, We help you eliminate pain and restore function via therapeutic exercise and education."

During the past decade, Guardian Angel Research Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 8 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guardian Angel Research Center" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 4 trials, followed by "Exact Sciences Corporation" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "4D pharma plc" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guardian Angel Research Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Guardian Angel Research Center" are "Ulcerative Colitis" (4 trials), "Colorectal Cancer" (2 trials), "Heartburn" (2 trials), "Hepatocellular Carcinoma" (2 trials) and "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials). Many other conditions were trialed in "Guardian Angel Research Center" in a lesser frequency.

Most popular intervention types in "Guardian Angel Research Center" are "Drug" (13 trials), "Other" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etrasimod" (4 trials), "Vonoprazan" (4 trials), "Lansoprazole" (2 trials) and "Amoxicillin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guardian Angel Research Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Guardian Angel Research Center". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Guardian Angel Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Guardian Angel Research Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".